The metabolic syndrome (MetS) is associated with nutrient surplus and kidney hyperfiltration, accelerating chronic renal failure. Mitochondria can be overwhelmed by substrate excess, leading to inefficient energy production and thereby tissue hypoxia. Mitochondrial dysfunction is emerging as an important determinant of renal damage, but whether it contributes to MetS-induced renal injury remains unknown. We hypothesized that early MetS induces kidney mitochondrial abnormalities and dysfunction, which would be notable in the vulnerable renal medulla. Pigs were studied after 16 weeks of diet-induced MetS, MetS treated for the last 4 weeks with the mitochondria-targeted peptide elamipretide (0.1 mg/kg SC q.d), and Lean controls (n 5 7 each). Single-kidney renal blood flow, glomerular filtration rate, and oxygenation were measured in-vivo, whereas cortical and medullary mitochondrial structure and function and renal injurious pathways were studied ex-vivo. Blood pressure was slightly elevated in MetS pigs, and their renal blood flow and glomerular filtration rate were elevated. Blood oxygen level-dependent magnetic resonance imaging demonstrated that this was associated with medullary hypoxia, whereas cortical oxygenation remained intact. MetS decreased renal content of the inner mitochondrial membrane cardiolipin, particularly the tetra-linoleoyl (C18:2) cardiolipin species, and altered mitochondrial morphology and function, particularly in the medullary thick ascending limb. MetS also increased renal cytochrome-c-induced apoptosis, oxidative stress, and tubular injury. Chronic mitoprotection restored mitochondrial structure, ATP synthesis, and antioxidant defenses and decreased mitochondrial oxidative stress, medullary hypoxia, and renal injury. These findings implicate medullary mitochondrial damage in renal injury in experimental MetS, and position the mitochondria as a therapeutic target. (Translational Research 2017;184:45-56) Abbreviations: MetS ¼ metabolic syndrome; GFR ¼ glomerular filtration rate; ROS ¼ reactive oxygen species; Ox-LDL ¼ oxidized low-density lipoprotein; ELAM ¼ elamipretide; mPTP ¼ mitochondrial permeability transition pore; PBS ¼ phosphate-buffered saline; PRA ¼ plasma renin activity; HOMA-IR ¼ homeostasis model assessment of insulin resistance; MDCT ¼ multi-detector computed tomography; BOLD-MRI ¼ blood oxygen level dependent magnetic resonance imaging; RVR ¼ renal vascular resistance; CRLS ¼ cardiolipin synthase; mTAL ¼ medullary thick ascending limb; PT ¼ proximal tubular; H2O2 ¼ hydrogen peroxide; Taz ¼ taffazin; COX ¼ cytochrome oxidase; SOD ¼ superoxide dismutase; TRX ¼ thioredoxin; PPAR ¼ peroxisome proliferator-activated receptor; OPA ¼ optic atrophy; DRP ¼ dynamin-related protein; LDH ¼ lactate dehydrogenase; TUNEL ¼ terminal deoxynucleotidyl transferase-mediated dUTP nickFrom the Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minn; Cardiovascular Diseases, Mayo Clinic, Rochester, Minn.
INTRODUCTION
The metabolic syndrome (MetS), a cluster of major cardiovascular risk factors related to dyslipidemia, obesity, and insulin resistance, affects over 20% of adults in Western populations. 1 Previous studies have linked MetS with development of chronic kidney disease, 2 and their co-existence is associated with increased cardiovascular disease mortality. 3, 4 Better understanding of the mechanisms triggering renal injury in MetS may help develop novel strategies to attenuate renal structural and functional deterioration in these patients.
To supply energy for active transport of solutes, renal tubular cells possess a high number of mitochondria, 5 which also maintain cellular homeostasis by regulating redox state, proliferation, apoptosis, and calcium signaling. 6 Emerging evidence suggests that in rodent models diabetic nephropathy is associated with mitochondrial dysfunction. For example, impaired mitochondrial complex-III in the kidney of genetic murine models of diabetes is associated with hyperfiltration and histopathological lesions. 7 Increased formation of reactive oxygen species (ROS) is likely a major contributor to mitochondrial dysfunction in diabetes, 8 as is hyperglycemia. Glucose overload has been associated with increased renal mitochondrial ROS production, which in turn damages mitochondrial proteins, lipids, and DNA, compromising ATP production, and ultimately impairing renal structure and function. 9 Indeed, preservation of the mitochondrial electron transport chain restores mitochondrial function and morphology and reduces glomerular hyperfiltration and proteinuria in mice with diabetic nephropathy. 10 However, whether mitochondrial injury and dysfunction are implicated in renal injury in pre-diabetic normoglycemic MetS remains to be clarified.
Early MetS is characterized by increased systemic markers of lipid oxidation, such as oxidized lowdensity lipoprotein (Ox-LDL) and isoprostanes, which contribute to the development of insulin resistance. 11 In the mitochondria, lipid peroxidation particularly afflicts cardiolipin, a phospholipid exclusively expressed on the inner mitochondrial membrane that plays a central role in preserving mitochondrial structure and function. 12 The mitochondria-targeted peptide elamipretide (ELAM) is a small compound that specifically binds with high affinity to cardiolipin to preserve or restore mitochondrial energetics. 12 Furthermore, this tetrapeptide possesses antioxidant properties and inhibits the activity of cytochrome-c peroxidase, a catalyzer of cardiolipin peroxidation that induced opening of the mitochondrial permeability transition pore (mPTP). We have previously shown that treatment with ELAM restores renal function in swine renovascular disease. 13, 14 Furthermore, a recent study shows that ELAM prevents high-fat diet-induced glomerulopathy and proximal tubular injury in mice, 15 but whether this approach attenuates renal injury in MetS has not been explored in a large preclinical experimental model. This study tested the hypothesis that in normoglycemic pigs, diet-induced MetS induces mitochondrial and tubular injury, which mitoprotection with ELAM would attenuate.
MATERIALS AND METHODS
Animal characteristics and experimental protocol. Twenty-one juvenile (3-month-old) female farm pigs were studied during 16 weeks of observation (Fig 1, A) . At baseline animals were randomized into 2 groups: MetS (n 5 14) and Lean (n 5 7). MetS pigs started a high-cholesterol/carbohydrate diet, 16 whereas Lean animals were fed with standard pig chow.
Twelve weeks later, 7 MetS pigs started a regimen of daily subcutaneous injections of ELAM (Stealth BioTherapeutics Inc), 0.1 mg/kg in 1 mL of phosphatebuffered saline (PBS), 5 d/wk, consistent with previous experiences with rabbits, pigs, and guinea pigs. 17, 18 A AT A GLANCE COMMENTARY
Background
Our study demonstrates that metabolic syndrome induces early structural and functional changes in the kidney, associated with renal mitochondrial abnormalities and dysfunction, particularly in the medullary thick ascending limb. Notably, chronic mitoprotection with the mitochondria-targeted peptide ELAM restores mitochondrial structure and function, improves medullary oxygenation, and decreases renal injury.
Translational Significance
Therefore, our observations implicate mitochondrial damage in renal injury and position mitochondria as a therapeutic target in experimental early metabolic syndrome.
PBS vehicle was injected in the remaining seven MetS pigs. Four weeks later, animals were anesthetized with IM tiletamine hydrochloride/zolazepam hydrochloride and xylazine, and maintained with intravenous ketamine and xylazine. Single-kidney hemodynamics and function were assessed using multi-detector computed tomography (MDCT) and renal oxygenation by blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI). Fasting blood samples were collected in anesthetized pigs before MDCT studies to assess the levels of lipids, isoprostanes, plasma renin activity (PRA), and creatinine, 19 and for measurements of glucose and insulin levels for calculation of the homeostasis model assessment of insulin resistance (HOMA-IR). 16, 20, 21 Mean arterial pressure was monitored during MDCT studies using an 8F arterial catheter inserted in the left carotid artery, as previously described. 22 One week after the completion of all studies, pigs were euthanized with a lethal intravenous dose of sodium pentobarbital. 14 The kidneys were removed using a retroperitoneal incision and immediately dissected, and sections frozen in liquid nitrogen or preserved in formalin or Trump's fixative for ex-vivo studies. For some assays, cortical and medullary tissues were discerned and analyzed separately.
In-vivo studies. BOLD-MRI was performed on a 3 Tesla scanner using fast gradient echo with multiple echo times to measure R2* levels (hypoxic index) in the renal medulla and cortex. Data were analyzed using a histogram-based compartmental method, 23 which provides comparable and less variable kidney R2* estimations and eliminates the need for anatomical cortical and medullary definition. MDCT scanning was performed 3-4 days after BOLD-MRI using a Flash-128 scanner, as previously described. 22, 24 A bolus of iopamidol was followed by a flow study, 140 scans, as per routine techniques. Using the Analyze software, crosssectional MDCT images were reconstructed, and renal volume, renal vascular resistance (RVR), renal blood flow (RBF), and glomerular filtration rate (GFR) measured, as previously described. 22, 24 Ex-vivo studies. Cardiolipin content, synthesis, and remodeling. Renal cardiolipin content was assessed by mass spectrometry, as described. 25 Renal expression of cardiolipin synthase (CRLS)-1 was measured by Western blot, 26 and mRNA expression of the cardiolipin remodeling enzyme taffazin (Taz)-1 27 by real-time quantitative polymerase chain reaction. 14 Mitochondrial morphology and function. Mitochondrial density and morphology was assessed in randomly selected medullary thick ascending limb (mTAL) and proximal tubular (PT) cells, representing cortical and medullary tubular segments, using a digital electron microscopy. The number of mitochondria/cell was averaged to obtain mitochondrial number, and mitochondrial area density measured using Image-J software. 28, 29 In addition, renal mitochondria were isolated from the cortex and medulla using the MITO-ISO kit, 30 and their ATP and ADP levels measured by colorimetric/fluorometric methods. Mitochondrial hydrogen peroxide (H 2 O 2 ) production was measured by colorimetric quantitative methods, 31 as well as glutathione activity (GSH/ GSSG) and NADPH generation (NADPH/NADP). Cortical and medullary expression of the cytochrome oxidase subunits (COX)-I, II, III, and IV, superoxide dismutase (SOD)-1, SOD-2, and thioredoxin (TRX)-2 were assessed by Western-blotting, 32 as were renal mitochondrial levels of peroxisome proliferatoractivated receptor (PPAR)-a, optic atrophy (OPA)-1, dynamin-related protein (DRP)-1, and p62.
Renal injury pathways. Renal cortical and medullary apoptosis was assessed in cross-sections of the kidney co-stained with terminal deoxynucleotidyl transferasemediated dUTP nick-end labeling (TUNEL) or activated caspase-3. 13, 33 Renal protein expression of the apoptosis regulators B-cell lymphoma (Bcl)-xl and Bcl2-associated X protein (Bax) was assessed by Western-blotting.
14 Renal mitochondrial cytochrome-c release was assessed by the ratio between its mitochondrial and cellular expression, and necrosis by cortical and medullary levels of lactate dehydrogenase (LDH). Renal lipid peroxidation and oxidative stress were evaluated by Ox-LDL staining 34 and in-situ production of superoxide anion by fluorescence microscopy using dihydroethidium. 19 Intrarenal fat deposition was measured by Oil-red-O staining. 21 Renal fibrosis was assessed in renal cross-sections stained with trichrome. 14 Tubular injury was scored in a blinded fashion in sections stained with Periodic acid-Schiff (PAS). 13 All quantifications were performed in a blinded manner.
Statistical methods. Results are expressed as mean 6 standard deviation. Comparisons within groups were performed using Student t test and among groups using analysis of variance, followed by Tukey's test as appropriate. Statistical significance was accepted for P # 0.05.
For details, please see online supplement.
RESULTS
After 16 weeks of MetS or lean diet, body weight, mean blood pressure, lipid fractions, fasting insulin, and HOMA-IR levels were significantly higher in MetS compared with Lean pigs (Table I) . Fasting glucose, serum creatinine, and PRA levels did not differ among the groups.
MetS induces renal hyperfiltration and medullary hypoxia. Cortical and medullary volumes were greater in MetS compared with Lean, and RBF and GFR were elevated (Table I) . Regional perfusion was relatively preserved, yet RVR decreased in MetS groups. Cortical oxygenation was unaltered, whereas medullary R2* (hypoxic index) was elevated in MetS (Table I) .
MetS
induces mitochondrial damage and dysfunction. Renal total cardiolipin content decreased in MetS compared with Lean (Fig 1, B) , particularly the tetra-linoleoyl (C18:2) cardiolipin species ( Figure S1 ). Contrarily, renal cardiolipin C18:1 and C18:0 were higher in MetS compared with Lean, as were renal cardiolipin hydrolysis products (lysocardiolipin; Fig 1, C) . Renal expression of CRLS-1 remained unaltered (Fig 1, D) , whereas mRNA expression of Taz-1 was reduced in MetS (Fig 1, E) . Electron microscopy revealed in MetS preserved renal tubular mitochondrial number and area (Fig 2,  A) . Contrarily, mitochondrial matrix density decreased in MetS mTAL, but not PT cells. The ratio of ATP/ ADP content in isolated renal cortical and medullary mitochondria decreased in MetS compared with Lean, suggesting impaired mitochondrial ATP synthesis (Fig  2, B) . Despite decreased ATP production, expression of COX subunits I, II, III, and IV was preserved in the cortex and medulla of MetS, suggesting impaired COX activity ( Figure S2 ).
Furthermore, mitochondrial oxidative stress increased in the medulla of MetS, reflected in elevated H 2 O 2 production (Fig 2, C) . In addition, medullary mitochondrial glutathione activity and generation of NADPH, as well as SOD-2 and TRX-2 expressions were blunted in MetS ( Figure S3 ), suggesting impaired mitochondrial antioxidant defenses.
Mitochondrial PPAR-a expression decreased in MetS ( Figure S4 ), suggesting decreased biogenesis, but OPA-1 levels were unchanged, indicating preserved fusion. Mitochondrial dynamin-related protein DRP-1 levels were higher in MetS, suggesting increased fission. Yet, expression of p62 was downregulated in MetS, indicating increased mitophagy ( Figure S4 ).
MetS induces early renal changes. The number of TU-NEL and caspase-3 positive cells was elevated in the MetS cortex and medulla compared with Lean (Fig 3,  A) , as was renal expression of Bax and Bax/Bcl-xl ratio (Fig 3, B) . Furthermore, the ratio of mitochondrial/ cellular cytochrome-c expression decreased in MetS compared with Lean (Fig 3, C) , suggesting release from mitochondria to the cytosol. LDH levels were also elevated in the MetS medulla compared with Lean (Fig 3, D) , implying increased necrosis.
Circulating levels of isoprostanes (Table I) , renal superoxide anion production (Fig 4, A) , and renal expression of Ox-LDL (Fig 4, B) were notably higher in MetS compared with Lean.
Intrarenal fat deposition was considerably greater in PT and mTAL of MetS ( Figure S5 , A-B), as was tubular injury (Fig 4, C) . Contrarily, tubulointerstitial fibrosis was unchanged (Fig 4, D) .
Mitoprotection
attenuates MetS-induced renal injury. Treatment with ELAM decreased medullary hypoxia (Table I ) and normalized renal cardiolipin content (Fig 1, B) and remodeling (Fig 1, E) . ELAM also restored cardiolipin species profile ( Figure S1 and 1, C) and improved mitochondrial density in mTAL cells (Fig 2, A) . In addition, ELAM normalized cortical and medullary ATP/ADP ratio (Fig 2, B) , and medullary H 2 O 2 production (Fig 2, C) , glutathione activity, NADPH generation, and SOD-2 abundance ( Figure S3 ). Furthermore, ELAM restored mitochondria-specific PPAR-a and p62 ( Figure S4 ) and decreased the number of TUNEL and caspase-3 positive cells (Fig 3, A) . Interestingly, renal expression of Bax remained unchanged, but the expression of Bcl-xl was exclusively upregulated in ELAM-treated pigs (Fig 3, B) , thereby normalizing Bax-Bcl-xl ratio, suggesting that ELAM attenuated renal apoptosis primarily by increasing the expression of anti-apoptotic factors rather than downregulating the expression of pro-apoptotic molecules. ELAM also prevented mitochondrial cytochrome-c release (Fig 3, C) and attenuated cortical and medullary necrosis (Fig 3, D) . Furthermore, tubular injury score decreased in MetS 1 ELAM-treated pigs (Fig 4, C) , whereas ELAM did not affect renal perfusion, RBF, or GFR. ELAM also decreased systemic and renal oxidative stress, illustrated by lower circulating levels of isoprostanes (Table I) , renal superoxide anion production (Fig 4, A) , and expression of OX-LDL (Fig 4, B) . 
DISCUSSION
This study shows that early MetS induces mitochondrial abnormalities and dysfunction, particularly in the mTAL, which is associated with glomerular hyperfiltration and medullary hypoxia. Furthermore, we found that chronic mitoprotection restored medullary mitochondrial structure and function, improved medullary oxygenation, and decreased renal injury, implicating mitochondrial damage in renal injury in experimental MetS and positioning the mitochondria as a therapeutic target.
To explore the mechanism underling MetS-induced renal injury, we took advantage of an early MetS swine model that recapitulates common features of human MetS, 16 and cutting-edge techniques that permit studying single-kidney function and structure. After 16 weeks of diet, our MetS pigs developed obesity and dyslipidemia, accompanied by a spontaneous increase in blood pressure and emergence of insulin resistance (HOMA-IR), indicating successful development of MetS. Contrarily, glucose levels remained unaltered, indicating non-diabetic MetS. Renal dysfunction in MetS pigs was characterized by hyperfiltration, evidenced by increased GFR, and associated with medullary hypoxia. Medullary volume increased in MetS compared with Lean, consistent with more extensive oxygen consumption, which leaves this region relatively more hypoxic compared with cortical segments. 35 MetS also induced renal apoptosis, which was greater in cortical than medullary regions, yet LDH levels were elevated only in the MetS medulla, implying increased necrosis. Given that under certain conditions renal apoptotic cells are unstable and undergo secondary necrosis, 36,37 our results suggest that medullary cells might have a higher propensity to switch from apoptosis to adverse necrosis. On the other hand, oxidative stress and tubular injury in MetS were elevated in both the cortex and medulla, underscoring the role of MetS as an important risk factor for kidney damage.
Moreover, the present study shows that renal injury and dysfunction are associated with renal mitochondrial abnormalities and dysfunction. We found that MetS decreased cardiolipin content, although CRLS-1 expression remained unchanged, arguing against MetS-induced modulation of de-novo cardiolipin synthesis. Furthermore, MetS impaired cardiolipin remodeling, reflected in decreased levels of Taz-1. Interestingly, MetS decreased 18:2 species, increased more saturated species like C18:1 and C18:0, as well as renal cardiolipin hydrolysis products (lyso-cardiolipin), implying cardiolipin oxidation. Cardiolipin is essential for cristae membrane formation and organizes the components of the electron transport chain, preserving mitochondrial integrity and structure. 27 In our MetS model, cardiolipin oxidation was accompanied by decreased mitochondrial density in mTAL, but not in PT cells, suggesting that MetS induces selective destabilization of cristae membranes in vulnerable mTAL cells.
Importantly, mitochondrial bioenergetics was also impaired. Mitochondrial ATP synthesis decreased in the cortex and medulla of MetS but was not associated with changes in COX subunit expression, implying decreased COX activity. Furthermore, early MetS increased medullary mitochondrial H 2 O 2 production and decreased mitochondrial antioxidant defenses, disclosed by reduced glutathione activity, NADPH generation, as well as SOD-2 and TRX-2 expression, consistent with the mitochondrial ROS overproduction and SOD-2 polymorphism observed in diabetes. 38, 39 ROS can damage cardiolipin, respiratory complex proteins, and nucleic acids, creating a vicious cycle that aggravates mitochondrial injury. Importantly, our study suggests that these alterations may precede overt diabetes or might be triggered by mechanisms other than elevated glucose levels. Renal adiposity, lipid peroxidation, and elevated levels of isoprostanes observed in MetS likely contribute to renal mitochondrial injury, given that mitochondrial cardiolipin commonly undergoes peroxidation and loss. 12, 40 Furthermore, MetS-induced hypoxia in the susceptible renal medulla, 41 revealed by BOLD-MRI, may compromise mitochondrial respiration, 42 whereas oxidative stress increases oxygen utilization, aggravating renal hypoxia. Reciprocally, decreased mitochondrial ATP synthesis may have partly contributed to medullary hypoxia in MetS, although we cannot rule out other contributing factors including changes in medullary volume, oxidative stress, apoptosis, necrosis, and tubular injury. Taken together, MetS-induced renal oxidative stress and hypoxia might contribute to mitochondrial abnormalities and dysfunction.
Furthermore, loss of cardiolipin impaired mitochondrial biogenesis, by decreasing the expression of PPAR-a. Although levels of the fusion marker OPA-1 remained unchanged, DRP-1 levels were higher and p62 lower in MetS compared with Lean, indicating increased mitochondrial fragmentation and degradation. Cardiolipin loss, increased mitochondrial H 2 O 2 production, and decreased mitochondrial redox-buffering capacity might have triggered renal oxidative stress, disclosed by increased Ox-LDL expression and in-situ production of superoxide anion. Oxidative stress can in turn amplify renal as well as myocardial dysfunction and injury in MetS. 43 Interestingly, tubulointerstitial fibrosis was yet undetectable in our MetS pigs, possibly due to the early stage of MetS.
Furthermore, we found that MetS-induced glomerular hyperfiltration, which characterizes both MetS and early diabetes and is associated with elevated metabolic risk. 44 We have previously shown that renal hyperfiltration in Ossabaw swine obesity is accompanied by significant intrarenal adiposity, oxidative stress, inflammation, and microvascular remodeling. 20, 21 Several factors have been identified as potential mediators of renal hyperfiltration in MetS, 45 including the effects of elevated insulin levels. Importantly, increased GFR and avid medullary tubular oxygendependent transport without a parallel increase in medullary perfusion might have contributed to medullary hypoxia observed in MetS pigs. Nevertheless, renal perfusion was preserved in MetS pigs, possibly due to vasodilation, implied by decreased RVR.
To establish the contribution of mitochondria to MetS-induced renal injury, we treated MetS pigs with ELAM, a compound that improves renal mitochondrial function in pigs with renovascular disease 13, 14 and in mice fed high-fat diet. 15 The present study extends previous observations, demonstrating that ELAM prevents cardiolipin loss, restores mitochondrial remodeling and redox status, and attenuates lipid peroxidation, likely due to a decrease in oxidative stress and an increase in antioxidant systems. Remarkably, mitoprotection in turn ameliorated renal injury (apoptosis, necrosis, oxidative stress, and tubular injury), implying that mitochondrial injury may contribute to development of renal injury and dysfunction in MetS. The capability to prevent cardiolipin peroxidation and loss, restore mitochondrial energetics, and inhibit cytochrome-c peroxidase activity confers ELAM with mitoprotective potency. Furthermore, inhibition of mPTP opening and release of cytochrome-c and ROS to the cytosol might have attenuated renal cell apoptosis and oxidative stress. Indeed, cytochrome-c-induced apoptosis, increased in MetS compared with Lean, normalized in ELAM-treated pigs.
This study is limited by the short duration of the diet, yet our model mimics many features of human disease, providing a solid experimental platform to study the effect of MetS on the kidney. Renal injury in our model is subtle, yet we identified several structural and functional changes in the kidney that place the mitochondria as an early target organelle for MetS. Although 4-week treatment with ELAM sufficed to confer protective effects, additional studies will need to explore its longterm effects on the kidney in MetS. The anesthetic regimen used in this study might have also masked a rise in blood pressure, as previous studies have shown that a combination of ketamine and xylazine decreases blood pressure by approximately 30%. 46 These drugs may have also induced acute hyperglycemia 47 or modulated plasma insulin levels, which could impact our assessment of insulin resistance. 48 Future studies are needed to test whether MetS-induced renal changes and the renoprotective properties of ELAM are observed in conscious pigs. Despite increased RBF and GFR in MetS pigs, PRA levels remain unchanged in MetS, consistent with our previous findings in swine obesity 49 and renovascular disease. 19 ELAM did not affect PRA levels, arguing against regulation of the systemic renin/angiotensin system, consistent with our previous finding that ELAM does not directly regulate vascular tone. 13 Further studies will be needed to explore an effect on blood pressure.
In summary, our study shows that MetS induces mitochondrial injury and early structural and functional changes in the kidney, characterized by glomerular hyperfiltration and medullary hypoxia, possibly related to increased oxidative stress, and mild tubular injury. Interestingly, the majority of the early changes were observed in the medulla, suggesting regional differences in renal susceptibility to MetS. Possibly, cellular apoptosis might have served to protect cortical tubular cells. Notably, chronic mitoprotection preserved mitochondrial bioenergetics and mTAL matrix density and improved renal structure. Although ELAM is rapidly removed from the plasma compartment, its action in the inner mitochondrial membrane is sustained for a longer period of time, prolonging its protective effects.
12 Therefore, our observations support a role for renal mitochondrial injury and dysfunction in experimental MetS. Further exploration of the role of mitochondria in MetS-induced renal disease could contribute to the development of adequate therapies to protect the kidney in these patients.
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Detailed Methods
Animal characteristics and experimental protocol. Twenty-one juvenile (3-month-old) female farm pigs were studied during 16 weeks of observation after approval by the Institutional Animal Care and Use Committee (Fig 1, A) . At baseline animals were randomized into two groups: MetS (n 5 14) and Lean (n 5 7). MetS pigs started a highcholesterol/carbohydrate diet (5B4L, protein 16.1%, ether extract fat 43.0%, and carbohydrates 40.8%, Purina Test Diet, Richmond, IN), 1 whereas Lean animals were fed with regular pig chow (13% protein, 2% fat, 6% fiber, Purina Animal Nutrition LLC, Minn).
Twelve weeks later, 7 MetS pigs started treatment with daily subcutaneous injections of the mitochondria-targeted peptide elamipretide (ELAM, Stealth BioTherapeutics, Inc Newton Centre, Mass), 0.1 mg/kg in 1 mL of PBS, 5 d/wk. A PBS vehicle was injected in the remaining seven MetS pigs.
Four weeks later, animals were anesthetized with 0.25 g of IM tiletamine hydrochloride/zolazepam hydrochloride (Telazol, Fort Dodge Animal Health, New York) and 0.5 g of xylazine and maintained with intravenous ketamine (0.2 mg/kg/min) and xylazine (0.03 mg/kg/min). Single-kidney hemodynamics and function were assessed using multi-detector computed tomography (MDCT) and renal oxygenation by blood oxygen level dependent magnetic resonance imaging (BOLD-MRI). Fasting blood samples were collected in anesthetized pigs during MDCT studies to assess levels of lipids, isoprostanes, plasma renin activity, and creatinine, 2 and for measurements of glucose and insulin levels for calculation of the homeostasis model assessment of insulin resistance (fasting plasma glucose 3 fasting plasma insulin/22.5). 1, 3, 4 Mean arterial pressure was monitored during MDCT studies using an 8F arterial catheter inserted in the left carotid artery, as previously described. 5 One week after the completion of all studies, pigs were euthanized with a lethal intravenous dose of 100 mg/kg of sodium pentobarbital (Fatal Plus, Vortech Pharmaceuticals, Dearborn, Mich). 6 The kidneys were removed using a retroperitoneal incision and immediately dissected, and sections frozen in liquid nitrogen (and maintained at 280 C) or preserved in formalin or Trump's fixative for ex-vivo studies. For some assays, cortical and medullary tissues were discerned and analyzed separately.
Lipid panel measurements. Total cholesterol levels were measured with an enzymatic colorimetric assay (Roche Cobas c311 chemistry analyzer, Roche Diagnostics, Indianapolis, Ind, 46250). Intra-assay coefficients of variations (CVs) are 1.0%, 1.1%, and 0.7% at 105, 250, and 301 mg/dL, respectively, and inter-assay CVs are 1.2%, 1.1%, and 1.3% at 107, 249, and 298 mg/dL, respectively. High-density lipoprotein levels were measured with a homogeneous enzymatic colorimetric assay (Roche Cobas c311 chemistry analyzer, Roche Diagnostics, Indianapolis, Ind, 46250). Intra-assay CVs are 0.8%, 0.6%, and 0.7% at 27, 51, and 74 mg/dL, respectively. Interassay CVs are 1.3%, 2.1%, and 2.6% at 27, 49, and 72 mg/dL, respectively. Triglycerides levels were measured with an enzymatic colorimetric assay (Roche Cobas c311 chemistry analyzer, Roche Diagnostics, Indianapolis, Ind, 46250). Intra-assay CVs are 0.8%, 0.8%, and 0.7% at 85, 178, and 340 mg/dL, respectively. Inter-assay CVs are 2.8%, 1.7%, and 0.7% at 86, 177, and 337 mg/dL, respectively. LDL levels were calculated with the following formula: total cholesterol-([Triglycerides/ 5] 1 high-density lipoprotein).
In-vivo studies. BOLD-MRI was performed on a 3 Tesla (GE Medical Systems, Milwaukee, Wis) scanner using fast gradient echo with multiple echo times to measure R2* levels in the renal medulla and cortex, as previously described. 7, 8 The principle of the BOLD method has been described in detail in previous publications. 9, 10 Briefly, paramagnetic molecules induce magnetic field perturbations. In the blood, oxyhemoglobin is diamagnetic and its concentration has no effect on T2*, but deoxyhemoglobin is paramagnetic and decreases tissue T2*. Therefore, when the echo time of the gradient echo MRI acquisition increases, the MRI signal attenuation increases with increased concentration of deoxyhemoglobin. The slope of Ln (intensity) vs echo time equals relaxation time rate R2* (51/T2) 9, 10 and is directly proportional to the concentration of deoxyhemoglobin. For BOLD-MRI studies, animals were sedated (Telazol 5 mg/kg and xylazine 2 mg/kg in saline, I.M), ventilated, and then anesthesia maintained with inhaled 1-2% isoflurane. MRI examinations were performed during suspended respiration. BOLD images were collected in oblique planes using 16 echoes. Imaging parameters were set to TR/TE/Flip Angle/FOV/Slice thickness/ Matrix 5 100 ms, 2.1-27 ms, 40 , 32 cm, 7 mm, 2563256. Axial and coronal images were collected with 2.5 mm thickness to reduce other sources of error (e.g. volume averaging and ASA) that could interfere with assessing the reproducibility. Data were analyzed using a histogram-based compartmental method, 11 which provides comparable and less variable kidney R2* estimations and eliminates the need for anatomical cortical and medullary definition. In this method, the traced ROIs included the entire kidney, and the R2* histogram of the tissue generated for values between 0-60 s21 at resolution of 0.5-1.0 s21. The upper limit of the R2* window was selected to include even the most hypoxic tissue, whereas excluding higher values that generally belong to areas affected by residual ASA. Because of their different distribution characteristics, cortical and medullary R2* distributions were approximated by Gaussian and gamma distribution functions, respectively, the validity of which was examined using statistical tests. In the cortex, normality of distributions was assessed by skewness and kurtosis, calculated for each of 22 swine kidneys by sampling 250 cortical pixels, and Bowman-Shenton normality distribution criteria was then investigated. Partial sampling was preferred over entire cortex ROIs to avoid regions even minimally affected by ASA, which might affect the skewness test. Medullary R2* in each kidney was sampled using an approach similar to the hybrid method. Multiple major distribution functions were examined against the data to find the closest function, based on the colinearity of probability plots. 12 All data were processed in MATLAB 7.10 (MathWorks Inc, Natick, Mass). R2* values were estimated by calculating the decay rate of MR signal by fitting signal intensity vs TE to a single exponential function in a voxel-byvoxel scheme. An R2* parametric map was created for each slice and used to avoid the areas affected by visible artifacts. The major source of artifact was ASA, which was recognized based on the location, pattern, and R2* values that were significantly higher than the surrounding cortical tissues. The mean R2* in cortex and medulla were then calculated using the manual ROI, hybrid, and compartmental methods.
MDCT scanning was performed 3 to 4 days after BOLD-MRI. MDCT is an ultra-fast scanner that provides accurate and noninvasive quantifications of single-kidney volume, regional perfusion, renal blood flow, and glomerular filtration rate. For MDCT studies, animals were anesthetized with 0.25 g of IM tiletamine hydrochloride/zolazepam hydrochloride (Telazol, Fort Dodge Animal Health, New York) and 0.5 g of xylazine and maintained with intravenous ketamine (0.2 mg/kg/ min) and xylazine (0.03 mg/kg/min). Axial images were acquired using a Flash 128 MDCT scanner (Somatom Definition Flash, Siemens Healthcare), as previously described. 5, 8 After tomographic localization of the kidneys, a bolus of iopamidol (0.5 cc/kg/2s) was followed by a flow study, 70 multi-scan exposures were acquired at a cycle time of 0.67 sec, followed by 70 scans at a cycle time of 2 sec, as per routine techniques. The volume images were reconstructed at 0.6 mm thickness with 0.3 mm overlap using the convolution kernel 5 B10f. Initiation of acquisition was set to trigger near the peak of the aorta intensity signal, such that the duration of acquisition time encompasses the vascular phase (maximal intensity) of contrast through the cortex of both kidneys. Regions of interest were selected from cross-sectional images from the aorta, renal cortex, and medulla. Average tissue attenuation in each region were plotted over time and fitted by curve-fitting algorithms to obtain measures of renal function. Cortical and medullary volumes were calculated by Analyze (Biomedical Imaging Resource, Mayo Clinic, Minn) and renal blood flow as the sum of the products of cortical and medullary perfusions and corresponding volumes. Glomerular filtration rate was calculated from the cortical curve using the slope of the proximal tubular curve, as previously described.
5,8
Ex-vivo studies.
Cardiolipin content and synthesis. Renal cardiolipin content was assessed by mass spectrometry. Lipids were extracted from the kidney tissue with a chloroform/methanol solution (Bligh Dyer extraction). Individual lipid extracts were reconstituted with chloroform:methanol (1:1), flushed with N2, and stored at 220 C for analysis via electrospray ionization mass spectrometry using a triple-quadrupole mass spectrometer with an automated nanospray apparatus. Enhanced multidimensional mass spectrometry-based shotgun lipidomics for cardiolipin and lyso-cardiolipin was performed, as previously described. 13 Renal expression of cardiolipin synthase (CRLS)-1 was measured by Western blot (CRLS1: LS-B12635).
14 mRNA expression of the cardiolipin regulator tafazzin (Taz)-1 was measured by real-time quantitative polymerase chain reaction.
Mitochondrial morphology and function. Mitochondrial density and morphology was assessed in medullary thick ascending limb (mTAL) and proximal tubular (PT) cells using a digital electron microscopy (Philips CM10 Transmission Electron Microscope). mTAL and PT cells were identified visually by well-recognized cell characteristics of diameter, shape, and size. Samples fixed with Trump's fixative were processed at the Mayo Clinic's electron microscopy core facility. For electron microscopy analysis, 3 mTAL and 3 PT epithelial cells were randomly selected for examination; the number of mitochondria/cell was counted and averaged to obtain mitochondrial number. Mitochondrial area and mitochondrial density were measured in 5 representative mitochondria in these cells using the National Institutes of Health Image-J software (version 1.44 for Windows), 15 which converts electron microscopic Figure S1 . Relative distribution of the major cardiolipin (CL) species observed in the kidney (n 5 7/group). *P # 0.05 vs Lean, †P # 0.05 vs MetS 1 ELAM. ELAM, elamipretide; MetS, metabolic syndrome. Figure S2 . Renal cortical and medullary expression of cytochrome oxidase (COX) subunits I, II, III, and IV in study groups (n 5 7/group). *P # 0.05 vs Lean, †P # 0.05 vs MetS 1 ELAM. ELAM, elamipretide; MetS, metabolic syndrome. 
Translational Research
56.e4 Eirin et al June 2017
56.e8 Eirin et al June 2017
